Senior Software Engineer at BioRender Inc. (Ats) (San Francisco, CA)

BioRender Inc. (Ats)· San Francisco, CA·1d ago

Role details

Work type

Hybrid

Employment

Full-Time

Job description

Culture: Described as a company of “passionate problem-solvers at the intersection of science and technology.” High employee rating of 4.3/5.0 on LinkedIn, with strong scores for Work-Life Balance (4.4) and Compensation (4.4). linkedin.com
Remote-First: Proudly remote-first across the US and Canada. Teams meet 2-4 times per year for events like hackathons and quarterly planning. Employees can work from another country for up to 3 months per year. biorender.com
Ownership & Equity: Employees are part owners of the company.
Benefits: Comprehensive health and dental benefits (including EAP, HSA, mental health), parental leave top-up with a “new baby bonus,” and a strong remote culture with virtual lunch & learns, games, and happy hours. biorender.com
Engineering & Product Focus: Active hiring for senior engineering roles (“Product Builder, Founder Track”) with salary ranges of $175K - $300K, indicating a strong commitment to attracting top technical talent. ycombinator.com

One-liner: BioRender provides a SaaS platform that enables scientists to create professional, publish-ready scientific figures and illustrations using a library of thousands of pre-made icons and templates.
Entity Type: Private (Venture-backed, Y Combinator W18 graduate)
Headquarters: Toronto, Ontario, Canada
Founded: 2017
Founders: Shiz Aoki (CEO), Katya Shteyn (CTO), Ryan Marien

Primary industry/industries: Scientific Communication Software, Life Sciences, Biotechnology
Target customers: B2B and B2C — researchers at universities, pharmaceutical companies, biotech firms, and scientific journals
Mission or purpose statement: “To accelerate the world’s ability to learn, discover and communicate science.” biorender.com

BioRender Platform (SaaS): The core offering is a web-based diagramming and illustration tool purpose-built for life scientists. It includes a library of over 30,000+ pre-made, scientifically accurate icons from over 30 fields of biology, as well as templates for pathways, mechanisms, and experimental setups. Users can create figures for grants, publications, presentations, and lab reports.
BioRender Content & Templates: Curated, peer-reviewed visual content that ensures scientific accuracy and consistency.
BioRender for Enterprise: Tailored solutions for large pharmaceutical companies and research institutions, including custom icon creation, API integrations, and advanced collaboration features.

Valuation/Market Cap: Not publicly disclosed.
Key Metrics:
- Total Funding: $17.3 million (as of latest venture round in December 2025) linkedin.com
- Annual Revenue: Not publicly available; company states it is “profitable” and on a “growth trajectory comparable to many top-performing SaaS companies.” biorender.com
- User Base: Over 3 million researchers globally at top universities, pharma companies, and journals.
- Scientific Figures Created: Over 24 million.
Notable Investors/Partners: Y Combinator (lead investor in multiple rounds, including Series A). ycombinator.com
Growth Signals:
- Headcount growth of 16.2% year-over-year (199 employees as of mid-2026) linkedin.com
- Active job postings increased 78.6% year-over-year (50+ open positions) linkedin.com
- Active hiring for senior roles including “Product Builder (Founder Track)”, reflecting a focus on high-impact engineering and product leadership. ycombinator.com

Deep Domain Moat: The most extensive, peer-reviewed library of scientific icons and templates in life sciences. No other tool has the same depth of curated, accurate visual content.
Trusted Brand: Used by over 3 million scientists and cited in millions of published figures. It is the de facto standard for scientific figure creation.
Network Effects: As more scientists create and share figures on the platform, the library grows and becomes more valuable to the entire community.
Profitability & Strong Unit Economics: Unlike many startups, BioRender is profitable, indicating a sustainable business model and product-market fit.

AI Integration: Leveraging AI to further accelerate the creation and communication of scientific visuals, helping researchers turn data into clear visuals faster.
Enterprise Expansion: Deepening relationships with large pharmaceutical companies and research institutions through dedicated enterprise features, API integrations, and custom content.
Platformization: Evolving from a simple figure-making tool into a comprehensive platform for all scientific visual communication, likely including collaboration, sharing, and version control.

Sources